5 active not recruiting. 5 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Active not recruiting 5 |
| Phase 1 | 2 | Active not recruiting 2 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Peritoneal Diseases: new trials by email Literature Review of Peritoneal Diseases trials Research Report on Peritoneal Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Galunisertib Combined With Capecitabine in Advanced CRC With PM Galunisertib plus capecitabine - Colorectal Cancer Metastatic, Peritoneal Carcinomatosis | Phase 1 / Phase 2 | Active not recruiting | The Netherlands Cancer Institute | 31 | 2023-07-28 | 2026-07-13 |
| Study of Sequential Systemic Therapy + Intraperitoneal Paclitaxel in Gastric/GEJ Peritoneal Carcinomatosis Paclitaxel, Leucovorin, Fluorouracil - Gastric Cancer, Peritoneal Carcinomatosis | Phase 2 | Active not recruiting | University of California, Irvine | 40 | 2021-02-18 | 2026-02-03 |
| Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma Cisplatin, Sodium thiosulfate, Cytoreductive surgery - Adrenocortical Carcinoma, Peritoneal Carcinomatosis | Phase 2 | Active not recruiting | Columbia University | 30 | 2017-09-22 | 2026-05-06 |
| Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases Perioperative systemic therapy, Perioperative CAPOX-bevacizumab, Perioperative FOLFOX-bevacizumab - Colorectal Neoplasm, Colorectal Cancer | Phase 2 / Phase 3 | Active not recruiting | Koen Rovers | 358 | 2017-06-01 | 2026-03-24 |
| PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer Olaparib, Tremelimumab - Ovarian Cancer, Fallopian Tube Cancer | Phase 1 / Phase 2 | Active not recruiting | New Mexico Cancer Research Alliance | 50 | 2016-02-23 | 2025-05-23 |
Peritoneal Neoplasms (5) · Colorectal Neoplasms (2) · Adrenocortical Carcinoma (1) · Colonic Neoplasms (1) · Fallopian Tube Neoplasms (1) · Hyperthermia (1) · Ovarian Neoplasms (1) · Stomach Neoplasms (1)
Abdominal Neoplasms (5) · Digestive System Diseases (5) · Digestive System Neoplasms (5) · Neoplasms (5) · Neoplasms by Site (5) · Gastrointestinal Diseases (3) · Gastrointestinal Neoplasms (3) · Colonic Diseases (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Intestinal Diseases (2) · Intestinal Neoplasms (2) · Rectal Diseases (2) · Adenocarcinoma (1)
Capecitabine (1) · Cisplatin (1) · Cytoreduction Surgical Procedures (1) · Fluorouracil (1) · LY-2157299 (1) · Leucovorin (1) · Paclitaxel (1) · olaparib (1) · sodium thiosulfate (1) · tremelimumab (1)
Columbia University (1) · Koen Rovers (1) · New Mexico Cancer Research Alliance (1) · The Netherlands Cancer Institute (1) · University of California, Irvine (1)
United States (3) · Netherlands (2) · Belgium (1)
Alexandra R Brandt-Kerkhof, MD (1) · Arend G Aalbers, MD (1) · Cornelis J Punt, MD, PhD (1) · Eino B van Duyn, MD, PhD (1) · Ignace H de Hingh, MD, PhD (1) · Jurriaan B Tuynman, MD, PhD (1) · Kazuki Sugahara, MD, PhD (1) · Maheswari Senthil, MD (1) · Marinus J Wiezer, MD, PhD (1) · Patrick H Hemmer, MD (1) · Pieter J Tanis, MD, PhD (1) · Sandra A Radema, MD, PhD (1) · Sarah F Adams, MD (1) · Wilhemina M van Grevenstein, MD, PhD (1)
PMID 31023318, PMID 33528867, PMID 34009291, PMID 36870941, PMID 42372745
2016 (1)